Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Selectra Biosciences
Selectra Biosciences
Selecta's rapamycin nanoparticles could enable re-dosing of gene therapies
BioCentury
Fri, 10/5/18 - 09:15 pm
Selectra Biosciences
SVP-Rapamycin
nanoparticles
gene therapy